HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series

TUCSON, Ariz. , Dec. 28, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling and advanced medicinal chemistry technology, provides here a summary of its second HTG